Overview
Spherix’s coverage of the dynamic renal anemia market monitors and closely tracks the evolving landscape of anemia of CKD treatments, including iron (oral and IV), ESAs, and upcoming (and highly anticipated) new HIF-PH inhibitors. Quarterly tracking, monthly pulses on new launches, and deep dives into patient date position Spherix uniquely as experts in this market.
Services Available
Trending market evolution
Renal Anemia (US)
Renal Anemia (EU)
Gauging impact of disruptive events
Nephrology Biosimilars Today and Tomorrow (US)
Renal Pipeline Tracker
Feedback from ASN Conference 2022 (US)
Nephrologist Feedback on [Current Market Event] (ongoing based on industry updates)